Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingxia Huayu Fang is a Traditional Chinese Medicine (TCM) formula composed of several herbal constituents, including red vine, Bupleurum, Corydalis, Salvia, red peony, Jiaoshan Gardenia, and raw rhubarb. It has demonstrated therapeutic effects in both clinical trials and animal studies for acute pancreatitis (AP) and its associated symptoms. The formula is believed to alleviate severe acute pancreatitis-associated intestinal injury by modulating Group 3 Innate Lymphoid Cells (ILCs) and improving intestinal barrier function, potentially mediated through the p38MAPK/ATF2 signaling pathway. In TCM theory, its effects include promoting defecation, clearing heat, regulating qi dynamics, and enhancing blood circulation. Clinical studies suggest it facilitates the recovery of gastrointestinal function in AP patients and shortens hospital stays.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingxia Huayu Fang.